HEALTHCARE & MEDICARE

What experts say about Hims & Hers' $1.15B acquisition of Eucalyptus

Experts say Hims & Hers' acquisition of Eucalyptus enables the company to address U.S. GLP-1 regulatory challenges, achieve global expansion and diversify revenue.

The post Experts weigh in on Hims & Hers's $1.15B acquisition of Eucalyptus appeared first on MedCity News.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button